Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
telmisartan angiotensin ii receptor type-1 NA Successful target TTD , DGIDB Hypertensive disease[MeSHID:D006973]
Congestive heart failure[MeSHID:D006333]
Diabetic Nephropathy[MeSHID:D003928]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 3.53 approved antagonist
telmisartan type-1 angiotensin ii receptor small molecule NA drugbank , DGIDB Hypertensive disease[MeSHID:D006973]
Congestive heart failure[MeSHID:D006333]
Diabetic Nephropathy[MeSHID:D003928]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 3.53 approved,investigational antagonist
telmisartan angiotensin ii receptor type-1 NA Successful target TTD , DGIDB Hypertensive disease[MeSHID:D006973]
Congestive heart failure[MeSHID:D006333]
Diabetic Nephropathy[MeSHID:D003928]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 3.53 approved unknown
telmisartan type-1 angiotensin ii receptor small molecule NA drugbank , DGIDB Hypertensive disease[MeSHID:D006973]
Congestive heart failure[MeSHID:D006333]
Diabetic Nephropathy[MeSHID:D003928]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 3.53 approved,investigational antagonist
telmisartan angiotensin ii receptor type-1 NA Successful target TTD , DGIDB Hypertensive disease[MeSHID:D006973]
Congestive heart failure[MeSHID:D006333]
Diabetic Nephropathy[MeSHID:D003928]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 3.53 approved unknown
telmisartan angiotensin ii receptor type-1 NA Successful target TTD , DGIDB Hypertensive disease[MeSHID:D006973]
Congestive heart failure[MeSHID:D006333]
Diabetic Nephropathy[MeSHID:D003928]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 3.53 approved antagonist
telmisartan peroxisome proliferator-activated receptor gamma small molecule NA drugbank Hypertensive disease[MeSHID:D006973]
Congestive heart failure[MeSHID:D006333]
Diabetic Nephropathy[MeSHID:D003928]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational partial agonist
telmisartan peroxisome proliferator-activated receptor gamma small molecule NA drugbank Hypertensive disease[MeSHID:D006973]
Congestive heart failure[MeSHID:D006333]
Diabetic Nephropathy[MeSHID:D003928]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 NA approved,investigational partial agonist
click here to return to the previous page